{"name":"Sichuan Kelun Pharmaceutical Co., Ltd","slug":"sichuan-kelun-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KLA578-1 for injection","genericName":"KLA578-1 for injection","slug":"kla578-1-for-injection","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"KLA578-1 for injection","genericName":"KLA578-1 for injection","slug":"kla578-1-for-injection","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPUlVsaXVFVXdpYjdHQW1BU3I4VVlhUWNPOWZKSVQ0anM4QjBGVVFjV2dsMzVTQlRNV0s4cW1nbE9vWTZELXhRZnExVU9ERmY3MlNLTTE2UmpfTWdzb0w4aGZ0MkR2X1NJZTlheDdiSkk1XzNBbXYzcENjanJoVXhXVTA3VjVfdFpIWW1qdzBoY3ItaUJmSUhCZnkxeW16M0loOEpnaWNvTV9KSDh2cWlzcHBraEQtNmtNTjdYSE5sa1h0Y3FReDZkV2t3QXlBVi1Ga2RmdEQ2SS1DXzV4TVJpbDlpNA?oc=5","date":"2026-04-02","type":"deal","source":"marketscreener.com","summary":"Tranche Update on Sichuan Kelun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 5, 2026. - marketscreener.com","headline":"Tranche Update on Sichuan Kelun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 5, 2026.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNRExNN21QMjBUR2luSzVRUHpwN1IzUHVHUHNjSkJHZTdDRE5SVktvZHJUTFRNUUExODU1SEpkM3NVUXZmV0M3eEpZSlBkbWg3dF9qQjUwSmhXQXRmZmgwNzRRbDFqR1VmU0tFRU5VdWM5el93SDM4eXpFS1M3b1Z5N2J6VDExT09tX0R3a3pfZXM4QVR1Z1VFd25BeVR1eFN4enVIYW9sX1VrYUpVOV9VLThLM2hFdFNoUWFPVVRqTUkyZlRNWjZxR2VFRQ?oc=5","date":"2026-03-25","type":"pipeline","source":"Markets Mojo","summary":"Sichuan Kelun Pharmaceutical Hits Day Low Amid Price Pressure at CNY 32.28 - Markets Mojo","headline":"Sichuan Kelun Pharmaceutical Hits Day Low Amid Price Pressure at CNY 32.28","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNMW1HWGJMWlo5dEdhYUFIaUNGWHlvN1N6Vkp6ZUF5bm9NU2I5SENjM2tyZXRMS05aUm5RaXBiXzhGLUpHNURTZ19oZWF4WWdSb08xa1pWY01UdjAyX3U0ZXM0cm00MTRfUXVBRnJFVnlZNnEtRk9YVWRDaW14SlhvODVfZ2hGVlhVWDBQdjNsYjExZmRBQ2RWZ2F4dFhUcm9SRERpcUp5RQ?oc=5","date":"2025-12-23","type":"pipeline","source":"BioWorld News","summary":"Big pharma taps fast Asia innovation in search of next Keytruda - BioWorld News","headline":"Big pharma taps fast Asia innovation in search of next Keytruda","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQU0xNdU1GbjdNM1hTSzY5QXlVVERxNGFWaEhtSU5YMHBxMURKT3gxT2U2V1hFMHNVa0Q1NE40SUc4SUV2RlNSUXc4Z1RNMW1kNmpWblNWSDBwbFZxb2NnQWhKN3ZKMFFhcUcxeXktUU5rbUdYODd1RFFxMEVBZHlCTHQyOUhHYXBpa1RWcHJxdFBDQnF2ZE9Yd1N6RVpKeVdZcjVKUE9zRkJldW9POUlqOA?oc=5","date":"2025-11-04","type":"pipeline","source":"Contract Pharma","summary":"Merck & Blackstone Enter Research and Development Funding Agreement - Contract Pharma","headline":"Merck & Blackstone Enter Research and Development Funding Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPcEltaEwtVll0Yzl0RkpRWmJBcFkyUWc0OU5NY3NfS2l2VS1hbnYxdUltX1I1LTlGTGpnOVRPVWdPdkJSZFNzU21FRzR1ZUstY05MX3Z3MmRKOUxjOHNKS0xsX1pkZ3dmWDhHbXJJQUYzVGJha3plbEdXRVVZV1FmOGI4a1BBWXZ5WlROek1qeUdMaDBFOFpvVmRIb1RmUG1GMXc?oc=5","date":"2025-08-18","type":"pipeline","source":"PR Newswire","summary":"KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS - PR Newswire","headline":"KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbXRYRG9qb3JJQmp6OGVjZHgyd0t2WTBrVXR3SFkzd0RFMWpaT2lhdVRVYmNqalZwbEZ3bE9wX0ZKT0p1VmRWeHFNYjl6VVdZX2twYkJHSzFQbU1qSVRYTGJfa0J1UHZsbFQwTXVQWWNiRkphSDdod3lzVU9aWkk1cVJtMTFtVDJa?oc=5","date":"2025-07-22","type":"pipeline","source":"BioWorld News","summary":"For big pharma, China is a shopper’s dream - BioWorld News","headline":"For big pharma, China is a shopper’s dream","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNVjNNalJrTVBBY084TENLSXEwVWJ2V2R1czJzdFZBVjBWN1BuOEpvWEFXU0ZNbnc3Ukk1TkNybDh3Z1BSd3djT1ZUZlNXNW5aZ0NrVFFpTFlvZDlockdNQzQ2RFhNWjQ4eUZlV1J2bC0yMVNXV3Z6RDF2MVdmLVZhSWxyNklxSVdFV0YwZFRVNXVyeDVtb2ZJQkdqRk5xd19zRnNNMDg1NGlNblZraXBJSXlEN21BUXVSYmwyWU9tQQ?oc=5","date":"2025-06-06","type":"pipeline","source":"PR Newswire","summary":"Kelun-Biotech Announces Approximately US$250 Million Placement - PR Newswire","headline":"Kelun-Biotech Announces Approximately US$250 Million Placement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE9iZG1NaEFwUmtFZF8tQnAzdzZlU3hUei1mbDdGS1l2MmVBMDk0bVUwbEdnMlRiemtrUnNvOEhBRjFmQzB1SmF1bDBXTUt3WVhfTERTUHp3?oc=5","date":"2024-05-31","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPMVV5S2E2MGxiMWN1V1N4RnhVdFJmUlUzbHE2b3duQXRmcHJtdU1uX0cyVURtREE3bUMtYXAzY3d3NnZoUnNQeTF2dEx5blcyMjRTc0RkSWhZSHpiNVFhV01tRExiSUJKV1hDRm1tSTNONFNZS2ZYY3VvWWFVb2dVSVJ3ajFDdzhzY19SZ0RDQTByeTdrM3pGWDNRN0RJeVo2ck42aHFMZUQtZUstb2NnMjExLTl4OFdydUx6NllFbEV0Vml1dHRIN2FMRm1udTBnaGFzT0EzSHUwV29pQ1E?oc=5","date":"2023-10-23","type":"pipeline","source":"Reuters","summary":"Merck discontinues some cancer drug development with China's Sichuan Kelun - Reuters","headline":"Merck discontinues some cancer drug development with China's Sichuan Kelun","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNLUVBenE3cmVXWGxBSmxSZDBrMjVzME50WHFXT3ZMZmRKQ2VLOERfQm9MaHBaOEtCUFVkNDJhV2ljNDlDLUFZSTQzaU1BenMtc2ZLa0huXzAxZzg5OUo0XzQwS3JqU2E0TzBqQzdMa0lPSExpR2ZSMExYNVg2RXJGcElPOGNoMXMwa2phRE84UlVhN0k?oc=5","date":"2022-12-22","type":"deal","source":"BioPharma Dive","summary":"Merck builds out cancer drug pipeline with Kelun-Biotech deal - BioPharma Dive","headline":"Merck builds out cancer drug pipeline with Kelun-Biotech deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxOZlRHekVSbVlsektGTUVoR0ZvTlpDZThrQk9XMVZZNEFESmtiMldnQUdrbzRxaEdGQ04zdWUzQVByM0I5T0F4bzFWektqa0RXeHM0SVBSdlpETnhfU0xBXzdIamFqcHVTbWFCRXRwWnhSREl6SWhFaUI3MlRpSVViQXhPb0o1djlxLVBlLWNQVWlpSVYxTlJQdE9QMld6YUFyMHowT1lTdzl1MUJkdmxtNmZUajQ3dVFGR3h3ZTJZTEFBWFcyMDdkQU5lWUdhZE91UWFTZFpkc1hkUDZ1MllVSVI3RDBPcGl0MXpNcjZWdw?oc=5","date":"2022-07-26","type":"deal","source":"globenewswire.com","summary":"Kelun-Biotech Announces Oncology Research Collaboration and License Agreement with MSD - globenewswire.com","headline":"Kelun-Biotech Announces Oncology Research Collaboration and License Agreement with MSD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5sRFUzVzVEQnlYSUlxcHMtRHc4aW1Fd0pteElLTnNKM2h3dU1ZNmNrRTBvZlJPdXp0ekl4enhRNm5vcUloVnVZR1FVY2t6MTRLYzhBemVBd0ZTMWlPTFFF?oc=5","date":"2021-11-26","type":"pipeline","source":"nature.com","summary":"Championing innovations for public and environmental health - nature.com","headline":"Championing innovations for public and environmental health","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}